Tunde Csepany
Overview
Explore the profile of Tunde Csepany including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
482
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dhondt R, Dedja K, Aerts S, Van Wijmeersch B, Kalincik T, Reddel S, et al.
Comput Methods Programs Biomed
. 2025 Feb;
263:108624.
PMID: 39965473
Background: Prognostic machine learning research in multiple sclerosis has been mainly focusing on black-box models predicting whether a patients' disability will progress in a fixed number of years. However, as...
2.
Siriratnam P, Huda S, van der Walt A, Sanfilippo P, Sharmin S, Foong Y, et al.
Neurology
. 2024 Nov;
103(12):e209940.
PMID: 39561307
Objectives: In aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-IgG NMOSD), disability accrual is mostly attributed to relapses. This study aimed to assess the prevalence of progression independent of relapse activity...
3.
Siriratnam P, Sanfilippo P, van der Walt A, Sharmin S, Foong Y, Yeh W, et al.
J Neurol Neurosurg Psychiatry
. 2024 Sep;
PMID: 39231582
Background: Neuromyelitis optica spectrum disorder (NMOSD) can be categorised into aquaporin-4 antibody (AQP4-IgG) NMOSD or seronegative NMOSD. While our knowledge of AQP4-IgG NMOSD has evolved significantly in the past decade,...
4.
De Brouwer E, Becker T, Werthen-Brabants L, Dewulf P, Iliadis D, Dekeyser C, et al.
PLOS Digit Health
. 2024 Jul;
3(7):e0000533.
PMID: 39052668
Background: Disability progression is a key milestone in the disease evolution of people with multiple sclerosis (PwMS). Prediction models of the probability of disability progression have not yet reached the...
5.
Bicsko R, Illes A, Hevessy Z, Ivady G, Kerekes G, Mehes G, et al.
Hematol Rep
. 2024 Apr;
16(2):255-259.
PMID: 38651454
The co-occurrence of myasthenia gravis (MG) and paroxysmal nocturnal hemoglobinuria (PNH) is rare; only one case has been published so far. We report a 63-year-old Caucasian female patient who was...
6.
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study
Dekeyser C, Hautekeete M, Cambron M, van Pesch V, Patti F, Kuhle J, et al.
J Neurol Neurosurg Psychiatry
. 2024 Apr;
95(11):1021-1031.
PMID: 38569872
Background: It remains unclear whether routine cerebrospinal fluid (CSF) parameters can serve as predictors of multiple sclerosis (MS) disease course. Methods: This large-scale cohort study included persons with MS with...
7.
Kalincik T, Sharmin S, Roos I, Freedman M, Atkins H, Burman J, et al.
JAMA Neurol
. 2023 Jul;
80(7):702-713.
PMID: 37437240
Importance: Autologous hematopoietic stem cell transplant (AHSCT) is available for treatment of highly active multiple sclerosis (MS). Objective: To compare the effectiveness of AHSCT vs fingolimod, natalizumab, and ocrelizumab in...
8.
Rajda C, Rozsa C, Mike A, Lovas G, Mezei Z, Jakab G, et al.
Orphanet J Rare Dis
. 2023 Jul;
18(1):183.
PMID: 37420270
Multiple sclerosis (MS) may impact quality of life, careers and family plans of the affected individuals. The current treatments with disease modifying therapies aim to prevent people with MS (pwMS)...
9.
Diouf I, Malpas C, Sharmin S, Roos I, Horakova D, Kubala Havrdova E, et al.
J Neurol Neurosurg Psychiatry
. 2023 Jul;
94(12):1004-1011.
PMID: 37414534
Background: Simultaneous comparisons of multiple disease-modifying therapies for relapsing-remitting multiple sclerosis (RRMS) over an extended follow-up are lacking. Here we emulate a randomised trial simultaneously comparing the effectiveness of six...
10.
Sharmin S, Roos I, Simpson-Yap S, Malpas C, Sanchez M, Ozakbas S, et al.
Brain
. 2023 Jun;
146(11):4633-4644.
PMID: 37369086
Geographical variations in the incidence and prevalence of multiple sclerosis have been reported globally. Latitude as a surrogate for exposure to ultraviolet radiation but also other lifestyle and environmental factors...